Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

The purpose of this study was to investigate the association between plasma vitamin D levels with hemoglobin concentration in pregnant women considering each trimester and iron supplementation.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cohort study.

Cohort study

Examines exposures and outcomes over time within a defined group.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

This was a prospective cohort study based on the Zhoushan Pregnant Women Cohort (ZPWC) from August 2011 to May 2018.

Source: Methods.

Pregnant women were recruited at their first prenatal visit between 8 and 14 gestational weeks.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Association of Vitamin D in Different Trimester with Hemoglobin during Pregnancy

Cohort study · Nutrients · 2022

Original publication title

Association of Vitamin D in Different Trimester with Hemoglobin during Pregnancy

Shuting Si; Zhicheng Peng; Haoyue Cheng; Yan Zhuang; Peihan Chi; Xialidan Alifu; Haibo Zhou; Minjia Mo; Yunxian Yu

© 2022 by the authors.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

The association between vitamin D and hemoglobin has been suggested. Vitamin D can affect erythropoiesis by the induction of erythroid progenitor cell proliferation and enhance iron absorption by regulating the iron-hepcidin-ferroportin axis in monocytes. However, this relationship in pregnant women is scarce. The purpose of this study was to investigate the association between plasma vitamin D levels with hemoglobin concentration in pregnant women considering each trimester and iron supplementation. The data were obtained from Zhoushan Pregnant Women Cohort, collected from 2011 to 2018.

Plasma 25(OH)D was measured in each trimester using liquid chromatography: tandem mass spectrometry. Generalized estimating equations and multiple linear regressions were performed. Finally, 2962 pregnant women and 4419 observations in the first trimester were included in this study. Plasma 25(OH)D in first trimester (T1) (β = 0.06, p = 0.0177), second trimester (T2) (β = 0.15, p < 0.0001), and third trimester (T3) (β = 0.12, p = 0.0006) were positively associated with Hb. Association between plasma 25(OH)D levels in T1 and Hb concentration was positively associated with gestational age (β = 0.005, p = 0.0421).

Pregnant women with VD deficiency in T1 (OR = 1.42, 95% CI: 1.07 to 1.88) or T2 (OR = 1.94, 95% CI: 1.30 to 2.89) presented an increased risk of anemia, compared with women without VD deficiency. Moreover, the significant relationship between VD and Hb was only observed among women with iron supplementation during pregnancy. Plasma 25(OH)D levels in each trimester were positively associated with Hb concentration. Iron supplementation might be an important factor affecting the relationship between VD and Hb.

Authors’ abstract

The association between vitamin D and hemoglobin has been suggested. Vitamin D can affect erythropoiesis by the induction of erythroid progenitor cell proliferation and enhance iron absorption by regulating the iron-hepcidin-ferroportin axis in monocytes. However, this relationship in pregnant women is scarce. The purpose of this study was to investigate the association between plasma vitamin D levels with hemoglobin concentration in pregnant women considering each trimester and iron supplementation. The data were obtained from Zhoushan Pregnant Women Cohort, collected from 2011 to 2018.

Plasma 25(OH)D was measured in each trimester using liquid chromatography: tandem mass spectrometry. Generalized estimating equations and multiple linear regressions were performed. Finally, 2962 pregnant women and 4419 observations in the first trimester were included in this study. Plasma 25(OH)D in first trimester (T1) (β = 0.06, p = 0.0177), second trimester (T2) (β = 0.15, p < 0.0001), and third trimester (T3) (β = 0.12, p = 0.0006) were positively associated with Hb. Association between plasma 25(OH)D levels in T1 and Hb concentration was positively associated with gestational age (β = 0.005, p = 0.0421).

Pregnant women with VD deficiency in T1 (OR = 1.42, 95% CI: 1.07 to 1.88) or T2 (OR = 1.94, 95% CI: 1.30 to 2.89) presented an increased risk of anemia, compared with women without VD deficiency. Moreover, the significant relationship between VD and Hb was only observed among women with iron supplementation during pregnancy. Plasma 25(OH)D levels in each trimester were positively associated with Hb concentration. Iron supplementation might be an important factor affecting the relationship between VD and Hb.

Publication and source details

Original title: Association of Vitamin D in Different Trimester with Hemoglobin during Pregnancy

Shuting Si; Zhicheng Peng; Haoyue Cheng; Yan Zhuang; Peihan Chi; Xialidan Alifu; Haibo Zhou; Minjia Mo; Yunxian Yu

Nutrients · 2022

* Correspondence: yunxianyu@zju.edu.cn; Tel.: +86-571-8820-8191© 2022 by the authors.2022https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).Chinese National Natural Science Foundation81973055National Key Research and Development Program of China2021YFC2701901Major research and development projects of Zhejiang Science and Technology Department2018C03010Key Laboratory of Intelligent Preventive Medicine of Zhejiang Province2020E10004Leading Innovative and Entrepreneur Team Introduction Program of Zhejiang2019R01007This study was funded by the Chinese National Natural Science Foundation (81973055), the National Key Research and Development Program of China (No. 2021YFC2701901), Major research and development projects of Zhejiang Science and Technology Department (2018C03010), Key Laboratory of Intelligent Preventive Medicine of Zhejiang Province (2020E10004) and Leading Innovative and Entrepreneur Team Introduction Program of Zhejiang (2019R01007).

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T07:40:23.414129+00:00

DOI: 10.3390/nu14122455 · PMC9230968